Closed · CDC-RFA-CD-23-0057 · CFDA 93.135 · Discretionary
Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease
Federal grant opportunity posted by Centers for Disease Control - OD, cataloged on Grants.gov.
- $1M-$3M
- Award range
- Closed
- Status
- May 22, 2023
- Close date
- 1
- Expected awards
The verdict
Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease is a closed discretionary listing from Centers for Disease Control - OD that offered $1,000,000 -- $3,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number.
- $1M-$3M
- award range
- Closed
- application status
- 1
- expected award
- 93.135
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease - is cataloged under number CDC-RFA-CD-23-0057 and tied to CFDA assistance listing 93.135, posted by Centers for Disease Control - OD. Grants.gov currently shows the opportunity as closed, first posted on April 7, 2023. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is $1,000,000 -- $3,000,000. The agency has projected $15.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $15.0 million estimated pool, the average award works out to roughly $15.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on May 22, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$1,000,000 -- $3,000,000
Close Date
May 22, 2023
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
April 7, 2023
Est. Total Funding
$15,000,000
Expected Awards
1
Instrument
Grant
Description
Primary Immunodeficiency Diseases (PID) are a group of primarily single-gene disorders of the immune system. Primary denotes the genetic nature of the defects, differentiating them from secondary or acquired immunodeficiencies caused by malnutrition, infection, chemotherapy, or other external agents. The defining characteristics of primary immunodeficiency diseases make them candidates for a public health intervention approach. Although the clinical manifestations and underlying genetic defects are diverse, primary immunodeficiency diseases share the common feature of increased susceptibility to infection and collectively result in substantial morbidity and shortened life spans. However prompt diagnosis and treatment can be lifesaving and may result in marked improvements in the quality and length of life. The heterogeneity of primary immunodeficiency diseases and the limited understanding of the relation between genotype and phenotype also hinder intervention efforts. Additional obstacles include the difficulty of diagnosis in the absence of a high index of suspicion and the lack of awareness of health care providers and the public which impedes the timely recognition of affected person by using a combination of clinical suspicion and diagnostic testing.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Scott Bowen msb4@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |